TDM of Digoxin and .BETA.-Methyldigoxin.
スポンサーリンク
概要
- 論文の詳細を見る
The relationships between serum glycoside concentrations, which were obtained from patients during maintenance therapy with digoxin (D3) or β-methyldigoxin (β-MD), and patient factors (age, sex, body weight and renal function) were investigated. Serum concentrations were measured by fluorescence polarization immunoassay with TDx digoxin assay kit (Dainabot). From February 1983 to July 1987, a total of 729 serum samples was received by our laboratory for therapeutic drug monitoring of D3 and β-MD and 182 of these samples were used for this study (D3-treated group, n=50; β-MD-treated group, n=132). For the patients with normal renal function (serum creatinine level≤1.3mg/dl) in each group, no significant differences of mean serum glycoside concentrations were observed between male and female, and none were also observed between patients aged over 60yr and ones aged under 60yr. Each serum glycoside concentration was correlated significantly with dose/kg of body weight [D3, r=0.412 (P<0.01); β-MD, r=0.415 (P<0.001)] and also with creatinine clearance [0.25mg D3, r=0.463 (P<0.01); 0.1mg β-MD, r=0.658 (P<0.001)]. When the serum glycoside concentrations were compared between the D3-treated group and the β-MD-treated group, the dosage ratio (β-MD/D3) to obtain the same serum concentrations was 0.6. However, over 60% of patients were given 0.25mg D3- or 0.1mg β-MD as daily dose and its dosage ratio was 1:0.4 (D3-: β-MD). On comparing the distribution of serum glycoside concentrations between both groups during maintenance therapy, the serum concentrations of the β-MD-treated group were found to be lower than those of the D3-treated group (Kolmogorov-Smirnov test: P<0.005).
- 一般社団法人 日本臨床薬理学会の論文
著者
-
熊谷 雄治
自治医科大学臨床薬理学
-
海老原 昭夫
自治医科大学臨床薬理
-
中島 創
大分医科大学医学部臨床薬理学
-
海老原 昭夫
自治医科大学
-
堤 喜美子
大分医科大学・文部
-
中島 創
大分医科大学臨床薬理
-
熊谷 雄治
自治医科大学臨床薬理
関連論文
- ブロマゼパムの薬物動態と薬効に及ぼすイトラコナゾールの影響
- クロニジン貼付剤M-5041T貼付時の血中クロニジン濃度に及ぼす入浴および季節の影響
- Amrinone のヒト手背静脈拡張作用に及ぼす加齢の影響 : Isoproterenol との比較
- Metoprolol の薬物動態に及ぼす Mexiletine の影響
- Lorazepam の薬物動態に及ぼすテレビゲームの影響
- 5. 抗不安薬の作用の出現のしかたに及ぼす説明法の影響 : 実験的検討(教育・プライマリーケア)
- 健常成人におけるバルプロ酸反復投与時の体内動態
- 卵巣癌患者におけるPaclitaxelの骨髄抑制自験例でのCAP療法・JP療法との比較
- 大分医科大学における臨床試験ワーキンググループ活動の紹介
- ニフェジピンの薬物動態に及ぼすクレメジン投与タイミングの影響 : アダラートカプセルにおける検討
- ニフェジピンの薬物動態に及ぼすクレメジン投与タイミングの影響
- 総合感冒薬の精神運動機能に及ぼす影響 : ワープロ数字入力作業を用いた検討
- テオフィリンの薬物動態に及ぼすセイヨウオトギリソウ(St. John's Wort:SJW)の影響
- 医学教育の中に「臨床薬理学」をどのように組み込むか? : 臨床薬物動態学とTDM
- Bromazepamの薬物動態と薬効に及ぼすFluconazoleの影響
- Triazolamの薬効に及ぼす摂食条件と投与タイミングの影響
- Digoxinの静脈内投与後の薬物動態に及ぼすClarithromycinおよびErythromycinの影響
- HPLC によるヒト血漿中ブロマゼパム未変化体分析法
- 臨床薬理センター創薬オフィス所属治験コーディネーターによる臨床試験の支援:創薬育薬クリニック構築を指向した試み
- 大分医科大学医学部附属病院における治験に参加した被験者に関する調査
- 妊娠時における肝薬物代謝能の変化 : カフェインを用いた検討
- 心拍数日内リズムにおける遺伝的関与の検討 : 第58回日本循環器学会学術集会
- 座長のことば : 「心不全の薬物療法」をとり上げるに当たって : 第57回日本循環器学会学術集会 : 第21回循環器教育セッション(教育講演)
- ヒスタミンH_2受容体遮断薬
- 臨床薬理学の立場から(臨床薬学をめぐる用語)
- 抗血栓薬
- 医薬品開発における諸問題
- 老年者の薬物動態 (第30回日本老年医学会総会記録) -- (老年者薬物治療の問題点)
- 高血圧症に伴う代謝異常と隆圧剤によるその修飾 (心血管系の異常と臨床検査)
- Furosemide は静脈拡張作用を有するか? : ヒト手背静脈における検討
- とくに降圧薬療法について(クオリティ・オブ・ライフを考える)
- わが国における臨床薬理学の現状と将来
- 新しい降圧薬のまとめ (高血圧へのアプロ-チ--プライマリ・ケアの実践) -- (高血圧の薬物療法)
- 降圧薬 (薬物療法の実際)
- β遮断薬の臨床薬理-降圧薬としての使用を中心として-
- Methyldopaによる薬剤性肝障害の2例
- Effect of diltiazem and cimetidine on the metabolism of Propranolol.
- Pharmacokinetics of beta-methyldigoxin. Comparison between the results by FPIA method and the results by post-separation assay method.
- Assessment of a simple method for acetylator phenotyping with caffeine.
- Polymorphous mode of caffeine metabolism in the Japanese poeple. On genotypes.
- Pharmacokinetics, pharmacodynamics, and safety of bevantolol, a new .BETA.1-selective .BETA.-adrenoceptor antagonist, in Japanese healthy volunteers.
- Clinical pharmacological studies on a new .BETA.1 selective .BETA.-blocker, bevantolol.
- Clinical pharmacology of ibopamine. (1). Safety and pharmacological actions after single and multiple oral doses in Japanese healthy subjects.
- TDM of Digoxin and .BETA.-Methyldigoxin.
- Pharmacokinetics of beta-methyldigoxin.
- Pharmacodynamics and pharmacological action in essential hypertension patient of calcium antagonist CS-905.
- Clinical phase I studies of a new antiemetic drug, SN-307 (ondansetron).
- Effects of prazosin and urapidil on the fingertip skin blood flow under cold exposure.
- タイトル無し
- 新しいヒスタミンH_2受容体遮断薬 Ranitidine の臨床薬理学的検討
- タイトル無し
- Clinic phase I study of migraine drug sumatriptan(SN-308).Single and repetitive subcutaneous injection test.
- Acute effect of denopamine for exercise tolerability of chronic heart failure patient.
- タイトル無し
- Effect of cimetidine, diltiazem on oxidative metabolism of theophylline.
- Effect of diltiazem on the pharmacodynamics of Ca antagonist, MPC-1304.
- Influence of diltiazem on antipyrine and trimethadione.
- Effect of diltiazem on pharmacokinetics of theophylline.
- タイトル無し
- Pharmacodynamics and pharmacological actions of MPC-1304, a Ca antagonist, in healthy adults.
- Effects of angiotensin II converting enzyme inhibitor enarapril on autonomic nervous system.
- Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of multiple oral administration.:Results of Multiple Oral Administration
- Effect of Food and Gastric Acidity on the Pharmacokinetics of MPC-1304, a New Calcium Channel Blocker.
- Effects of MPC-1304 on blood flow of the finger tip.
- Effect of ranitidine on urinary excretion by furosemide.
- Clinical pharmacology of a new antiplatelet drug, KBT-3022. Results of single administration in Japanese healthy adults.
- Clinical pharmacology of a new antiplatelet drug, KBT-3022. Studies on repeated administration in healthy adults.
- Clinical pharmacology of ibopamine. (2). Pharmacokinetics after single and multiple oral administration in healthy Japanese subjects.
- Circadian variation in blood pressure in case of administration of various types of hypotensive drugs.
- Effects of ageing on liver metabolism of Propranolol.On oxidation, and conjugation reaction.
- Effect of renal function on pharmacodynamics of beta-methyldigoxin.
- Pharmacodynamics of beta-methyldigoxin in renal dialysis patient.
- タイトル無し
- タイトル無し
- タイトル無し
- タイトル無し
- Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of single oral administration.:Results of Single Oral Administration
- Various types of caffeine metabolism in Japanese people. Studies by urine per 2 hours.
- Effect of diltiazem on the reduction in exercise-induced tachycardia and kinetic parameters of propranolol or atenolol.
- Phase I study of a clonidine patch, M-5041T.(2).
- タイトル無し
- Influence of Aging on the Oxidative and Conjugative Metabolism of Propranolol.
- The effect of the aging on pharmacokinetics and hypotensive response of Nitrendipine.
- Chronopharmacologic research of new thromboxane A2 receptor antagonist S-1452.
- Effects of ageing on the effect of Atenolol.Study of the density - effect relation using effect compartment model.
- タイトル無し
- Phase I study of a new Ca antagonist, SN305(lacidipine).
- Pharmacokinetics of beta-methyldigoxin.
- Comparison of clonidine patches and hypotensive effects on daytime and at night.
- Phase I study of therapeutic drug for hemicrania, Sumatriptan(SN-308).
- Clinical Phanmacology of a Newly Synthesized Anti-lipidemic Agent (CGA)
- タイトル無し
- Effect of ageing on pharmacodynamics of Propranolol optical isomer.
- The effect of Furosemide on urinary excretion of Lomefloxacin.
- Clinical pharmacology of a new thromboxantin A2 receptor antagonist S-1452.
- Comparison between direct assay and separating assay of blood beta-methyldigoxin by fluorescent polarized immunoassay.
- タイトル無し
- タイトル無し
- タイトル無し
- Effect of captopril on urinary excretion of furosemide.